Ironsides Asset Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Ironsides Asset Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-40,049	Closed	-$2.34M	–	86
2016 Q4	$2.34M	Buy	40,049 +2,235	+6%	+$122K	0.64%	38
2016 Q3	$2.04M	Buy	37,814 +1,414	+4%	+$90.8K	0.55%	43
2016 Q2	$2.69M	Sell	36,400 -624	-2%	-$44.1K	0.82%	25
2016 Q1	$2.37M	Sell	37,024 -305	-0.8%	-$19.2K	0.59%	38
2015 Q4	$2.57M	Buy	37,329 +361	+1%	+$23.9K	0.69%	32
2015 Q3	$2.19M	Hold	36,968	–	–	0.61%	34
2015 Q2	$2.46M	Buy	36,968 +373	+1%	+$24.6K	0.7%	32
2015 Q1	$2.36M	Sell	36,595 -190	-0.5%	-$11.9K	0.64%	33
2014 Q4	$2.17M	Sell	36,785 -4,600	-11%	-$259K	0.6%	36
2014 Q3	$2.12M	Buy	41,385 +781	+2%	+$39K	0.61%	38
2014 Q2	$1.97M	Buy	+40,604	New	+$2M	0.57%	40

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ironsides Asset Advisors's BMY Position: Q1 2017 in Review

Ironsides Asset Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 40,049 shares — an estimated $2.34M sold.

Ironsides Asset Advisors first reported a position in BMY in Q2 2014 and held it in 11 quarters. The position peaked at $2.69M in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Ironsides Asset Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
Ironsides Asset Advisors sold 40,049 Bristol-Myers Squibb shares in Q1 2017, an estimated $2.34M.
Ironsides Asset Advisors first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 11 quarters.
Ironsides Asset Advisors's Bristol-Myers Squibb position peaked at $2.69M in Q2 2016.
1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Ironsides Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.